Drugs / OrniFlu
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02229357 | Jun → Sep 2014 | avian influenza | Mahidol University | Completed | No outcome recorded |
| Phase 2 | NCT02153671 | May → Sep 2014 | — | PATH | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OrniFlu | “Immunogenicity of OrniFlu® Inactivated Influenza Vaccine in Subjects Previously Immunized With Live Attenuated H5N2 Influenza Vaccine and in Non-vaccinated Subjects” NCT02153671 ↗ |
| Modality | Vaccine | “inactivated influenza vaccine” NCT02153671 ↗ |
| Route | Intramuscular | “Two doses were administered intramuscularly 28 days apart.” NCT02153671 ↗ |